drugset / Trial / NCT00569374
Safety and Tolerability of Modafinil for Methamphetamine Dependence
Phase 2
Completed
8 enrolled
University of Arkansas
National Institute on Drug Abuse (NIDA) · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This 7 week, open-label pilot clinical trial will examine the safety and tolerability of modafinil up to 400mg/day as a potential treatment to reduce methamphetamine use in methamphetamine-dependent volunteers.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Modafinil | Small molecule | 400 mg | Oral |